Who Owns Trevi Therapeutics Stock?
NASDAQ: TRVIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 107.77%
- Institutions (% of float)
- 108.45%
- Held by insiders
- 0.63%
- Institutional holders
- 291
- Institutions 99.4%
- Insiders 0.6%
- Public and other 0.0%
Who owns Trevi Therapeutics stock?
Institutional investors own about 107.8% of Trevi Therapeutics's shares, spread across 291 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.63% of TRVI.
The largest institutional holders are FMR, LLC (9.56%), NEA Management Company, LLC (9.27%) and Blackrock Inc. (8.62%). Together, the top 10 institutions control 52.7% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their TRVI positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of TRVI
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 13.63M | 9.56% | +8.5% |
| NEA Management Company, LLC | 13.22M | 9.27% | 0.0% |
| Blackrock Inc. | 12.29M | 8.62% | +10.2% |
| Frazier Life Sciences Management, L.P. | 9.54M | 6.69% | -4.0% |
| Wellington Management Group, LLP | 6.24M | 4.37% | +9.7% |
| Vanguard Capital Management LLC | 6.11M | 4.29% | +10.5% |
| Vivo Capital, LLC | 4.23M | 2.97% | -17.0% |
| Assenagon Asset Management S.A. | 3.53M | 2.47% | +131.2% |
| State Street Corporation | 3.27M | 2.30% | +8.1% |
| Marshall Wace LLP | 3.15M | 2.21% | +17.8% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of TRVI
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 4.05M | 2.84% |
| iShares Trust-iShares Russell 2000 ETF | 2.82M | 1.98% |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 2.66M | 1.87% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 2.33M | 1.64% |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 1.95M | 1.37% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.35M | 0.95% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.17M | 0.82% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 1.04M | 0.73% |
| iShares Trust-iShares Russell 2000 Growth ETF | 1.03M | 0.72% |
| AB CAP FUND, INC.-AB Small Cap Growth Portfolio | 996.06K | 0.70% |
Frequently asked questions
Who is the largest shareholder of Trevi Therapeutics?
FMR, LLC is the largest institutional shareholder of TRVI, owning 9.56% of shares outstanding (13.63M shares) as of its latest 13F filing.
What percentage of Trevi Therapeutics is owned by institutions?
Institutions own about 107.8% of TRVI shares and 108.5% of the public float.
How much of Trevi Therapeutics do insiders own?
Insiders, such as officers and directors, own about 0.63% of TRVI shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.